P A Velasquez-Mieyer

Summary

Affiliation: University of Tennessee
Country: USA

Publications

  1. ncbi Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults
    P A Velasquez-Mieyer
    Department of Pediatrics, University of Tennessee Health Science Center, Memphis, USA
    Int J Obes Relat Metab Disord 27:219-26. 2003
  2. ncbi Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects
    P A Velasquez-Mieyer
    Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38103, USA
    Int J Obes Relat Metab Disord 27:1359-64. 2003
  3. ncbi Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults
    P A Velasquez-Mieyer
    Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38103, USA
    Int J Obes Relat Metab Disord 28:330-3. 2004
  4. ncbi Racial disparity in glucagon-like peptide 1 and inflammation markers among severely obese adolescents
    Pedro A Velasquez-Mieyer
    Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA
    Diabetes Care 31:770-5. 2008
  5. ncbi Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus
    Pedro A Velasquez-Mieyer
    University of Tennessee Health Science Center and the University of Tennessee Lifestyle Diabetes and Obesity Center, Department of Pediatrics, Memphis, TN 38103, USA
    Expert Opin Pharmacother 9:2377-82. 2008
  6. ncbi Assessing the risk of impaired glucose metabolism in overweight adolescents in a clinical setting
    P A Velasquez-Mieyer
    Department of Pediatrics, University of Tessessee Health Science Center, 50 North Dunlap, Memphis, TN 38103, USA
    J Nutr Health Aging 12:750S-757S. 2008
  7. ncbi Obesity and cardiometabolic syndrome in children
    Pedro Velasquez-Mieyer
    Dept of Pediatrics, LeBonheur Children s Medical Center, 50 North Dunlap, Memphis, TN 38103, USA
    Ther Adv Cardiovasc Dis 1:61-81. 2007
  8. ncbi Obesity, leptin resistance, and the effects of insulin reduction
    R H Lustig
    Department of Pediatrics, University of California, San Francisco, CA 94143 0434, USA
    Int J Obes Relat Metab Disord 28:1344-8. 2004
  9. ncbi Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children
    Robert H Lustig
    Division of Pediatric Endocrinology, Department of Pediatrics, University of California, San Francisco, USA
    J Pediatr 148:23-9. 2006

Research Grants

  1. Race, Obesity and Enteroinsular Axis in Adolescents
    Pedro Velasquez Mieyer; Fiscal Year: 2007

Detail Information

Publications9

  1. ncbi Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults
    P A Velasquez-Mieyer
    Department of Pediatrics, University of Tennessee Health Science Center, Memphis, USA
    Int J Obes Relat Metab Disord 27:219-26. 2003
    ..We investigated whether suppression of insulin secretion, without dietary or exercise intervention, could promote weight loss and alter food intake and preference in obese adults...
  2. ncbi Racial differences in glucagon-like peptide-1 (GLP-1) concentrations and insulin dynamics during oral glucose tolerance test in obese subjects
    P A Velasquez-Mieyer
    Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38103, USA
    Int J Obes Relat Metab Disord 27:1359-64. 2003
    ..The increased GLP-1 concentration could explain the greater insulin concentration and the increased prevalence of hyperinsulinemia-associated disorders including obesity and type 2 diabetes in AAs...
  3. ncbi Race affects insulin and GLP-1 secretion and response to a long-acting somatostatin analogue in obese adults
    P A Velasquez-Mieyer
    Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN 38103, USA
    Int J Obes Relat Metab Disord 28:330-3. 2004
    ....
  4. ncbi Racial disparity in glucagon-like peptide 1 and inflammation markers among severely obese adolescents
    Pedro A Velasquez-Mieyer
    Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee, USA
    Diabetes Care 31:770-5. 2008
    ....
  5. ncbi Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus
    Pedro A Velasquez-Mieyer
    University of Tennessee Health Science Center and the University of Tennessee Lifestyle Diabetes and Obesity Center, Department of Pediatrics, Memphis, TN 38103, USA
    Expert Opin Pharmacother 9:2377-82. 2008
    ..The objective of this review was to evaluate evidence-based information using biphasic insulin aspart 30 in the treatment of type 1 diabetes mellitus...
  6. ncbi Assessing the risk of impaired glucose metabolism in overweight adolescents in a clinical setting
    P A Velasquez-Mieyer
    Department of Pediatrics, University of Tessessee Health Science Center, 50 North Dunlap, Memphis, TN 38103, USA
    J Nutr Health Aging 12:750S-757S. 2008
    ....
  7. ncbi Obesity and cardiometabolic syndrome in children
    Pedro Velasquez-Mieyer
    Dept of Pediatrics, LeBonheur Children s Medical Center, 50 North Dunlap, Memphis, TN 38103, USA
    Ther Adv Cardiovasc Dis 1:61-81. 2007
    ..This review provides rationale for additional assessments to determine cardiometabolic risk in overweight youth and recommends treatment options...
  8. ncbi Obesity, leptin resistance, and the effects of insulin reduction
    R H Lustig
    Department of Pediatrics, University of California, San Francisco, CA 94143 0434, USA
    Int J Obes Relat Metab Disord 28:1344-8. 2004
    ..They also support the possibilities that hyperinsulinemia may be a proximate cause of leptin resistance, and that reduction of insulinemia may promote weight loss by improving leptin sensitivity...
  9. ncbi Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children
    Robert H Lustig
    Division of Pediatric Endocrinology, Department of Pediatrics, University of California, San Francisco, USA
    J Pediatr 148:23-9. 2006
    ....

Research Grants2

  1. Race, Obesity and Enteroinsular Axis in Adolescents
    Pedro Velasquez Mieyer; Fiscal Year: 2007
    ..The results of this study can be translated into medical practice changes and may help to implement a more physiologically effective approach to obesity treatment in AA adolescents, in particular. ..